Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Introduction

Parsonage-Turner Syndrome is an uncommon cause of shoulder pain.

Case Representation

Herein, we present the case of a male in his 40s, who was presented with a 3-month history of acute onset of intense shoulder pain, which decreased rapidly leaving behind a residual upper limb weakness. The diagnosis of Parsonage-Turner Syndrome following COVID-19 vaccination was made based on electroneuromyography and magnetic resonance imaging findings. The patient responded well to analgesics and rehabilitation.

Conclusion

A better knowledge of this disease and early recognition are crucial to prevent unnecessary tests and interventions.

Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863322806240808095118
2024-09-06
2025-09-11
Loading full text...

Full text loading...

References

  1. MitchellC. AdebajoA. HayE. CarrA. Shoulder pain: diagnosis and management in primary care.BMJ200533175251124112810.1136/bmj.331.7525.1124 16282408
    [Google Scholar]
  2. SmithC.C. BevelaquaA.C. Challenging pain syndromes: Parsonage-Turner syndrome.Phys. Med. Rehabil. Clin. N. Am.201425226527710.1016/j.pmr.2014.01.001 24787332
    [Google Scholar]
  3. van AlfenN. Clinical and pathophysiological concepts of neuralgic amyotrophy.Nat. Rev. Neurol.20117631532210.1038/nrneurol.2011.62 21556032
    [Google Scholar]
  4. van AlfenN. van EngelenB.G.M. The clinical spectrum of neuralgic amyotrophy in 246 cases.Brain2006129243845010.1093/brain/awh722 16371410
    [Google Scholar]
  5. FranszD.P. SchönhuthC.P. PostmaT.J. van RoyenB.J. Parsonage-Turner syndrome following post-exposure prophylaxis.BMC Musculoskelet. Disord.201415126510.1186/1471‑2474‑15‑265 25098693
    [Google Scholar]
  6. CorneaA. LataI. SimuM. RoscaE.C. Parsonage-Turner Syndrome Following SARS-CoV-2 Infection: A Systematic Review.Biomedicines202311383710.3390/biomedicines11030837 36979815
    [Google Scholar]
  7. SerorP. Neuralgic amyotrophy. An update.Joint Bone Spine201784215315810.1016/j.jbspin.2016.03.005 27263426
    [Google Scholar]
  8. WatadA. De MarcoG. MahajnaH. Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.Vaccines (Basel)20219543510.3390/vaccines9050435 33946748
    [Google Scholar]
  9. SloumaM. MhemliT. AbbesM. Rheumatoid arthritis occurring after coronavirus disease 2019 (COVID-19) infection: Case based review.Egypt. Rheumatol.202244327527810.1016/j.ejr.2022.03.001 37521095
    [Google Scholar]
  10. FurrT. GargM. Rare cases of Polymyalgia Rheumatica after receiving COVID-19 vaccinations.Cureus2023154e3778210.7759/cureus.37782 37091488
    [Google Scholar]
  11. ArinoH. MuramaeN. OkanoM. MoriK. OtsuiK. SakaguchiK. Acute Onset of Remitting Seronegative Symmetrical Synovitis With Pitting Edema (RS3PE) Two Weeks After COVID-19 Vaccination With mRNA-1273 With Possible Activation of Parvovirus B19: A Case Report With Literature Review.Cureus2022145e2495210.7759/cureus.24952 35706724
    [Google Scholar]
  12. SloumaM. AbbesM. KharratL. GharsallahI. Post-COVID-19 reactive arthritis.Clin. Rheumatol.20224182609261010.1007/s10067‑022‑06241‑9 35788920
    [Google Scholar]
  13. SloumaM. AbbesM. MehmliT. Reactive arthritis occurring after COVID-19 infection: a narrative review.Infection2023511374510.1007/s15010‑022‑01858‑z 35655110
    [Google Scholar]
  14. KimJ.E. ParkJ. MinY.G. HongY.H. SongT.J. Associations of neuralgic amyotrophy with COVID ‐19 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.Muscle Nerve202266676677010.1002/mus.27734 36214181
    [Google Scholar]
  15. RoscaE.C. Al-QiamiA. CorneaA. SimuM. Parsonage–Turner Syndrome following COVID-19 Vaccination: A Systematic Review.Vaccines (Basel)202412330610.3390/vaccines12030306 38543940
    [Google Scholar]
  16. Van EijkJ.J.J. GroothuisJ.T. Van AlfenN. Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment.Muscle Nerve201653333735010.1002/mus.25008 26662794
    [Google Scholar]
  17. FuruhataR. MatsumuraN. OkiS. Risk factors of radiographic severity of massive rotator cuff tear.Sci. Rep.20221211356710.1038/s41598‑022‑17624‑y 35945235
    [Google Scholar]
  18. Nové-JosserandL. EdwardsT.B. O’ConnorD.P. WalchG. The acromiohumeral and coracohumeral intervals are abnormal in rotator cuff tears with muscular fatty degeneration.Clin. Orthop. Relat. Res.2005433909610.1097/01.blo.0000151441.05180.0e 15805942
    [Google Scholar]
  19. HalderA.M. ZhaoK.D. OdriscollS.W. MorreyB.F. AnK.N. Dynamic contributions to superior shoulder stability.J. Orthop. Res.200119220621210.1016/S0736‑0266(00)00028‑0
    [Google Scholar]
  20. Van SnickE. ValgaerenB. ClaikensB. Parsonage-Turner Syndrome.J. Belg. Soc. Radiol.202310713310.5334/jbsr.3088 37124325
    [Google Scholar]
  21. ScalfR.E. WengerD.E. FrickM.A. MandrekarJ.N. AdkinsM.C. MRI findings of 26 patients with Parsonage-Turner syndrome.AJR Am. J. Roentgenol.20071891W39-4410.2214/AJR.06.1136 17579134
    [Google Scholar]
  22. FeinbergJ.H. RadeckiJ. Parsonage-Turner Syndrome.HSS J.20106219920510.1007/s11420‑010‑9176‑x 21886536
    [Google Scholar]
  23. Al KhaliliY. JainS. LamJ.C. DeCastroA. Brachial Neuritis.StatPearls.Treasure Island, FLStatPearls Publishing2024 29763017
    [Google Scholar]
  24. IyerV.G. ShieldsL.B. ZhangY.P. ShieldsC.B. Clinical spectrum of postsurgical Parsonage-Turner Syndrome: A perspective from an electrodiagnostic laboratory.Cureus2023156e4100110.7759/cureus.41001 37503467
    [Google Scholar]
  25. UpadhyayaV. UpadhyayaD.N. BansalR. PandeyT. PandeyA.K. MR neurography in Parsonage-Turner syndrome.Indian J. Radiol. Imaging201929326427010.4103/ijri.IJRI_269_19 31741594
    [Google Scholar]
  26. CignettiN.E. CoxR.S. BauteV. A standardized ultrasound approach in neuralgic amyotrophy.Muscle Nerve202367131110.1002/mus.27705 36040106
    [Google Scholar]
  27. ArÁnyiZ CsillikA DéVayK Ultrasonography in neuralgic amyotrophy: Sensitivity, spectrum of findings, and clinical correlations.Muscle Nerve20175661054106210.1002/mus.25708 28556181
    [Google Scholar]
  28. WolnyT. GlibovK. GranekA. LinekP. Ultrasound diagnostic and physiotherapy approach for a patient with Parsonage–Turner Syndrome: A case report.Sensors (Basel)202323150110.3390/s23010501 36617093
    [Google Scholar]
  29. CassartEM VilasDR AbeR Cavanilles-WalkerJM Parsonage-Turner syndrome after COVID-19 vaccination in a child.J Am Acad Orthop Surg Glob Res Rev202373e22.0015610.5435/JAAOSGlobal‑D‑22‑00156
    [Google Scholar]
  30. Van EijkJ.J.J. Van AlfenN. BerrevoetsM. Van der WiltG.J. PillenS. Van EngelenB.G.M. Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: An observational study.J. Neurol. Neurosurg. Psychiatry200980101120112410.1136/jnnp.2008.163386 19321467
    [Google Scholar]
  31. NaitoK. FukushimaK. SuzukiS. Intravenous immunoglobulin (IVIg) with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy: Clinical observations in 10 cases.Intern. Med.201251121493150010.2169/internalmedicine.51.7049 22728480
    [Google Scholar]
  32. JohnsonN.E. PetragliaA.L. HuangJ.H. LogigianE.L. Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin.Muscle Nerve201144230430510.1002/mus.22100 21717467
    [Google Scholar]
/content/journals/cds/10.2174/0115748863322806240808095118
Loading
/content/journals/cds/10.2174/0115748863322806240808095118
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test